Evidence map›Paper›PMID 39258539›Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Overview of ADNI MRI.

Clifford R Jack, Arvin Arani, Bret J Borowski, Dave M Cash, Karen Crawford, Sandhitsu R Das, Charles DeCarli, Evan Fletcher, Nick C Fox, Jeffrey L Gunter and 17 more

Abstract readReview
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. MIND diet-related plasma proteins are associated with Alzheimer's disease risk.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Sex specificity of resistance to caTAUstrophe.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Clifford R JackDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Arvin AraniDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Bret J BorowskiDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Dave M CashDementia Research Centre, University College London Institute of Neurology, Queen Square, London, UK.
Karen CrawfordLaboratory of Neuro Imaging (LONI), University of Southern California, Los Angeles, California, USA.
Sandhitsu R DasDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Charles DeCarliDepartment of Neurology, University of California, Davis, California, USA.
Evan FletcherDepartment of Neurology, University of California, Davis, California, USA.
Nick C FoxDementia Research Centre, University College London Institute of Neurology, Queen Square, London, UK.
Jeffrey L GunterDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Ranjit IttyerahDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Danielle J HarveyDepartment of Public Health Sciences, Division of Biostatistics, University of California, Davis, California, USA.
Neda JahanshadKeck School of Medicine of USC, Los Angeles, California, USA.
Pauline MaillardDepartment of Neurology, University of California, Davis, California, USA.
Ian B MaloneDementia Research Centre, University College London Institute of Neurology, Queen Square, London, UK.
Talia M NirKeck School of Medicine of USC, Los Angeles, California, USA.
Robert I ReidDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Denise A ReyesDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Christopher G SchwarzDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Matthew L SenjemDepartment of Information Technology, Mayo Clinic, Rochester, Minnesota, USA.
David L ThomasDepartment of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London, UK.
Paul M ThompsonLaboratory of Neuro Imaging (LONI), University of Southern California, Los Angeles, California, USA.
Duygu TosunDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA.
Paul A YushkevichDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Chadwick P WardDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Michael W WeinerDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA.
Alzheimer's Disease Neuroimaging Initiative

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI CLIFFORD R. JACK · 2016 to 2026
$226.7M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Charles DeCarli, Rachel A Whitmer · 2021 to 2026
$25.2M
Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkersR37AG011378 · NIA · MAYO CLINIC ROCHESTER · PI CLIFFORD R. JACK · 2018 to 2026
$6.8M
Validating the New Criteria for Preclinical Alzheimer's diseaseR01AG041851 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R., KNOPMAN, DAVID S · 2012 to 2021
$6.3M
High resolution mapping of the genetic risk for disease in the aging brainR01AG059874 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JAHANSHAD, NEDA · 2018 to 2022
$3.1M
Ex Vivo Imaging of the Aging Brain to Discover Morphology/Pathology AssociationsRF1AG056014 · NIA · UNIVERSITY OF PENNSYLVANIA · PI YUSHKEVICH, PAUL A. · 2023 to 2023
$2.1M
Improving the sensitivity and specificity of MRI-based biomarkers in Alzheimer's diseaseR01AG069474 · NIA · UNIVERSITY OF PENNSYLVANIA · PI WOLK, DAVID A, YUSHKEVICH, PAUL A. · 2024 to 2025
$1.4M
NIA NIH HHS P30 AG072972NIA NIH HHS P30 AG072979NIA NIH HHS R01 AG041851NIA NIH HHS R01 AG059874NIA NIH HHS R01 AG069474NIA NIH HHS R37 AG011378NIA NIH HHS RF1 AG056014NIA NIH HHS U19 AG024904NIH HHS R01 AG041851NIH HHS R37 AG011378NIH HHS U19AG24904
6 · The paper itself

Abstract

The magnetic resonance imaging (MRI) Core has been operating since Alzheimer's Disease Neuroimaging Initiative's (ADNI) inception, providing 20 years of data including reliable, multi-platform standardized protocols, carefully curated image data, and quantitative measures provided by expert investigators. The overarching purposes of the MRI Core include: (1) optimizing and standardizing MRI acquisition methods, which have been adopted by many multicenter studies and trials worldwide and (2) providing curated images and numeric summary values from relevant MRI sequences/contrasts to the scientific community. Over time, ADNI MRI has become increasingly complex. To remain technically current, the ADNI MRI protocol has changed substantially over the past two decades. The ADNI 4 protocol contains nine different imaging types (e.g., three dimensional [3D] T1-weighted and fluid-attenuated inversion recovery [FLAIR]). Our view is that the ADNI MRI data are a greatly underutilized resource. The purpose of this paper is to educate the scientific community on ADNI MRI methods and content to promote greater awareness, accessibility, and use. HIGHLIGHTS: The MRI Core provides multi-platform standardized protocols, carefully curated image data, and quantitative analysis by expert groups. The ADNI MRI protocol has undergone major changes over the past two decades to remain technically current. As of April 25, 2024, the following numbers of image series are available: 17,141 3D T1w; 6877 FLAIR; 3140 T2/PD; 6623 GRE; 3237 dMRI; 2846 ASL; 2968 TF-fMRI; and 2861 HighResHippo (see Table 1 for abbreviations). As of April 25, 2024, the following numbers of quantitative analyses are available: FreeSurfer 10,997; BSI 6120; tensor based morphometry (TBM) and TBM-SYN 12,019; WMH 9944; dMRI 1913; ASL 925; TF-fMRI NFQ 2992; and medial temporal subregion volumes 2726 (see Table 4 for abbreviations). ADNI MRI is an underutilized resource that could be more useful to the research community.

Indexed as

Alzheimer DiseaseMagnetic Resonance ImagingNeuroimagingBrainHumansADNIAlzheimer's disease imagingAlzheimer's disease MRImagnetic resonance imaging

Identifiers

PMID39258539
PMCPMC11485416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.